Back to search

Article

Brain metabolic resilience conferred by the APOE3 Christchurch variant in autosomal dominant Alzheimer’s disease and across the adult lifespan

2026-08-14

Abstract excerpt

<title>Abstract</title> <p> The <italic>APOE3</italic> Christchurch ( <italic>APOE3</italic> <sup> <italic>Ch</italic> </sup> ) is a rare genetic variant associated with marked protection against autosomal-dominant Alzheimer’s disease (ADAD) due to the <italic>PSEN1</italic> <sup> <italic>E280A</italic> </sup> variant, by delaying the onset of clinical symptoms. In this study, we investigate age-rela...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a8acc6f2-b965-552e-ad0a-ecd079b1abb8
DOI
10.21203/rs.3.rs-10145165/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Brain metabolic resilience conferred by the APOE3 Christchurch variant in autosomal dominant Alzheimer’s disease and across the adult lifespanDOI 10.21203/rs.3.rs-10145165/v1
Select a neighboring publication to make it the new centre.